Cytokines and Chemokines in Mycobacterium tuberculosis Infection

R Domingo-Gonzalez, O Prince, A Cooper… - Microbiology …, 2016 - journals.asm.org
Chemokines and cytokines are critical for initiating and coordinating the organized and
sequential recruitment and activation of cells into Mycobacterium tuberculosis-infected …

Tocilizumab (actemra)

M Sheppard, F Laskou, PP Stapleton… - Human vaccines & …, 2017 - Taylor & Francis
Tocilizumab (TCZ), is a recombinant humanized anti-interleukin-6 receptor (IL-6R)
monoclonal antibody which has a main use in the treatment of rheumatoid arthritis, systemic …

Adalimumab in patients with active noninfectious uveitis

GJ Jaffe, AD Dick, AP Brézin, QD Nguyen… - … England Journal of …, 2016 - Mass Medical Soc
Background Patients with noninfectious uveitis are at risk for long-term complications of
uncontrolled inflammation, as well as for the adverse effects of long-term glucocorticoid …

Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked …

QD Nguyen, PT Merrill, GJ Jaffe, AD Dick, SK Kurup… - The Lancet, 2016 - thelancet.com
Background Non-infectious uveitis is a potentially sight-threatening ocular disorder caused
by chronic inflammation and its complications. Therapeutic success is limited by systemic …

[HTML][HTML] Is Mycobacterium tuberculosis infection life long?

MA Behr, PH Edelstein, L Ramakrishnan - Bmj, 2019 - bmj.com
Is Mycobacterium tuberculosis infection life long? | The BMJ Skip to main content Intended for
healthcare professionals Access provided by Google Indexer Subscribe My Account My email …

Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis

S Minozzi, S Bonovas, T Lytras, V Pecoraro… - Expert opinion on …, 2016 - Taylor & Francis
Introduction: Five anti-tumor necrosis factor (anti-TNF) agents have received regulatory
approval for use in rheumatology: adalimumab, golimumab, infliximab, certolizumab, and …

The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment

J Listing, K Gerhold, A Zink - Rheumatology, 2013 - academic.oup.com
RA is known to be associated with an increased risk of serious infection. Even more than 50
years ago, observational studies showed a greater than 2-fold increased risk of serious …

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in …

T Bongartz, AJ Sutton, MJ Sweeting, I Buchan… - Jama, 2006 - jamanetwork.com
ContextTumor necrosis factor (TNF) plays an important role in host defense and tumor
growth control. Therefore, anti-TNF antibody therapies may increase the risk of serious …

EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

S Van Assen, N Agmon-Levin, O Elkayam… - Annals of the rheumatic …, 2011 - Elsevier
Objectives To develop evidence-based European League Against Rheumatism (EULAR)
recommendations for vaccination in patients with autoimmune inflammatory rheumatic …

The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis

CR Holroyd, R Seth, M Bukhari, A Malaviya… - …, 2019 - academic.oup.com
Christopher R. Holroyd1, Rakhi Seth1, Marwan Bukhari2, Anshuman Malaviya3, Claire
Holmes1, Elizabeth Curtis4, Christopher Chan1, Mohammed A. Yusuf3, Anna Litwic4, 5 …